维普期刊资源整合服务平台（V6.5）

80篇 您的检索式：作者名="Eberhard DA"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients显示文摘	Yauch RL Januario T Eberhard DA	2005	Clin Cancer Res2005，11，241：	1
2	Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with Erlotinib 显示文摘	Eberhard DA Johnson BE Amler LC	2005	J Clin Oncol2005，23，：	1
3	Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients显示文摘	Yauch RL Januario T Eberhard DA	2005	Clin Cancer Res2005，11，24：	1
4	Mutations in the epidermal growth factor receptor and in K-ras are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib显示文摘	Eberhard DA Johnson BE Amler LC	2005	J Clin Oncol2005，23，25：	1
5	Hstopatholgy of arteriovenorsal for mationafteer gamma Knife radiosurger显示文摘	Schneider BF Eberhard DA Steiner LE	1997	J Neur lsurg1997，87，3：	1
6	Histopathology of arteriovenous malformations after gamma knife radiosurgery 显示文摘	Eberhard DA Steiner LE	1997	J Neurosurg1997，87，3：	1
7	Histopathology of arteriovenous malformations after gamma knife radiosurgery 显示文摘	Schneider BF Eberhard DA Steiner LE	1997	J Neurosurg1997，87，3：	1
8	Pleomorphic xanthoastrocytoma, a distinctive astroglial tumor: neuroradiologic and pathologic features显示文摘	Lipper MH Eberhard DA Phillips CD	1993	AJNR1993，14，6：	1
9	Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small- cell lung cancer treated with chemotherapy alone and in combination with erlotinib 显示文摘	Eberhard DA Johnson BE Amler LC	2005	J Clin Oncol2005，23，25：	1
10	Epithelial versus mesenchymal phenotype determines in vitro sensitiv- ity and predicts clinical activity of erlotinib in lung cancer patients 显示文摘	Yauch RL Januario T Eberhard DA	2005	Chn Cancer Res2005，11，24：	1
11	Mutations in the epidermal growth factor receptor and in KRAS are pre- dictive and prognostic indicators in patients with non - small- cell lung cancer treated with chemotherapy alone and in combination with erlotinib显示文摘	Eberhard DA Johnson BE Amler LC	2005	J Clin Oncol2005，23，：	1
12	Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small cell lung cancer treated with chemotherapy alone and in combination with erlotinib显示文摘	Eberhard DA Johnson BE Amler LC	2005	J Clin 0ncol2005，23，25：	1
13	Mutations in the epidermal growth factor receptor and in KRAS are pre- dictive and prognostic indicators in patients with non- small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib 显示文摘	Eberhard DA Johnson BE Amler LC	2005	J Clin Oncol2005，23，：	1
14	Histopatholgy of arteriovenous malformation after gamma knife radiosurgery 显示文摘	Schneider BF Eberhard DA Steiner LE	1997	J Neurosurg1997，87，3：	1
15	Epithelial versusmesenchymal phenotype determines in vitro sensitivity andpredicts clinical activity of erlotinib in lung cancer patients 显示文摘	Yauch RL Januario T Eberhard DA	2005	Clin Cancer Res2005，11，241：	1
16	Mutations in the epidermal growth factor receptor and in K-RAS are predictive and prognostic indicators in patients with nonsmall cell lung cancer treated with chemotherapy alone and in combination with erlotinib显示文摘	Eberhard DA Johnson BE AmLer LC		0，，25：	1
17	Biomarkers of response to epidermal growth factor receptor inhibitors in non-small-cell lung cancer working group:Standardization for use in the clinical trial setting显示文摘	Eberhard DA Giaccone G Johnson BE	2008	Clin Oncol2008，26，6：	1
18	Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients显示文摘	Yauch RL Januario T Eberhard DA	2005	Clin Cancer Res2005，11，24：	1
19	EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer显示文摘	Varella-Garcia M Diebold J Eberhard DA	2009	J Clin Pathol2009，62，11：	1
20	Mutations in the epider-mal growth factor receptor and in KRAS are predictive and prognosticindicators in patients with non-small-cell lung cancer treated withchemotherapy alone and in combination with erlotinib显示文摘	Eberhard DA Johnson BE Amler LC	2005	J Clin On-col2005，23，25：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示